These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10518647)

  • 1. Formula optimization based on artificial neural networks in transdermal drug delivery.
    Takayama K; Takahara J; Fujikawa M; Ichikawa H; Nagai T
    J Control Release; 1999 Nov; 62(1-2):161-70. PubMed ID: 10518647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer.
    Wu PC; Obata Y; Fujikawa M; Li CJ; Higashiyama K; Takayama K
    J Pharm Sci; 2001 Aug; 90(8):1004-14. PubMed ID: 11536204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network.
    Obata Y; Li CJ; Fujikawa M; Takayama K; Sato H; Higashiyama K; Isowa K; Nagai T
    Int J Pharm; 2001 Jan; 212(2):223-31. PubMed ID: 11165080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting mechanism of menthol derivative, 1-O-ethyl-3-buthylcyclohexanol, on the percutaneous absorption of ketoprofen.
    Li CJ; Higashiyama K; Yoshimura Y; Nagai T; Takayama K; Obata Y
    Biol Pharm Bull; 2001 Sep; 24(9):1044-8. PubMed ID: 11558566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen.
    Obata Y; Sato H; Li CJ; Takayama K; Higashiyama K; Nagai T; Isowa K
    Int J Pharm; 2000 Apr; 198(2):191-200. PubMed ID: 10767568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiomenthol derivatives as novel percutaneous absorption enhancers.
    Takanashi Y; Higashiyama K; Komiya H; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1999 Jan; 25(1):89-94. PubMed ID: 10028423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: in vitro and in vivo study.
    Wu PC; Chang JS; Huang YB; Chai CY; Tsai YH
    Int J Pharm; 2001 Jul; 222(2):225-35. PubMed ID: 11427353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability.
    Rhee GJ; Woo JS; Hwang SJ; Lee YW; Lee CH
    Drug Dev Ind Pharm; 1999 Jun; 25(6):717-26. PubMed ID: 10349557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers.
    Zhao L; Fang L; Xu Y; Liu S; He Z; Zhao Y
    Eur J Pharm Biopharm; 2008 May; 69(1):199-213. PubMed ID: 18065216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ketoprofen formulations via penetration rate and irritation in vivo study.
    Huang YB; Wang RJ; Chang JS; Tsai YH; Wu PC
    Int J Pharm; 2007 Jul; 339(1-2):47-51. PubMed ID: 17382500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
    Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
    Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
    Zhao L; Fang L; Xu Y; Zhao Y; He Z
    Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural network as a novel method to optimize pharmaceutical formulations.
    Takayama K; Fujikawa M; Nagai T
    Pharm Res; 1999 Jan; 16(1):1-6. PubMed ID: 9950271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
    Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
    Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
    So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
    Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mode of promoting activity of O-ethylmenthol as a transdermal absorption enhancer.
    Obata Y; Maruyama Y; Takayama K
    Pharm Res; 2006 Feb; 23(2):392-400. PubMed ID: 16467993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A statistical approach to the development of a transdermal delivery system for ondansetron.
    Obata Y; Ashitaka Y; Kikuchi S; Isowa K; Takayama K
    Int J Pharm; 2010 Oct; 399(1-2):87-93. PubMed ID: 20705125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal Adhesive Patches Loaded with Ketoprofen Evaluated by Dynamic Detection of Percutaneous Absorption.
    Wang M; Li L; Xie J; Sun Y; Ling G; He Z
    AAPS PharmSciTech; 2017 Aug; 18(6):2141-2148. PubMed ID: 28035612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formula optimization of theophylline controlled-release tablet based on artificial neural networks.
    Takayama K; Morva A; Fujikawa M; Hattori Y; Obata Y; Nagai T
    J Control Release; 2000 Aug; 68(2):175-86. PubMed ID: 10925126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.